Two-Headed PROTAC: An Effective New Tool for Targeted Protein Degradation

被引：43
|
作者：
Cyrus, Kedra [1 ]
Wehenkel, Marie [1 ]
Choi, Eun-Young [2 ]
Swanson, Hollie [2 ]
Kim, Kyung-Bo [1 ]
机构：
[1] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA
来源：
CHEMBIOCHEM | 2010年 / 11卷 / 11期
关键词：
estrogen receptor; ligases; PROTAC; proteomics; ubiquitin-proteasome pathway; ARYL-HYDROCARBON RECEPTOR; CHIMERIC MOLECULES; CHEMICAL GENETICS; UBIQUITINATION; BINDING; SCF;
D O I：
10.1002/cbic.201000222
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Better than one: A novel class of PROTAC that recruits target protein for ubiquitination and subsequent degradation by the proteasome has been successfully synthesized and tested for its activity to degrade a target protein. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码：1531 / 1534
页数：4
相关论文
共 50 条
  • [31] New two-headed sphingolipid-like compounds from the marine sponge Oceanapia sp.
    Makarieva, T. N.
    Guzii, A. G.
    Denisenko, V. A.
    Dmitrenok, P. S.
    Stonik, V. A.
    RUSSIAN CHEMICAL BULLETIN, 2008, 57 (03) : 669 - 673
  • [32] Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies
    Drummond, Michael L.
    Henry, Andrew
    Li, Huifang
    Williams, Christopher, I
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (10) : 5234 - 5254
  • [33] New two-headed sphingolipid-like compounds from the marine sponge Oceanapia sp.
    T. N. Makarieva
    A. G. Guzii
    V. A. Denisenko
    P. S. Dmitrenok
    V. A. Stonik
    Russian Chemical Bulletin, 2008, 57 : 669 - 673
  • [34] Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
    Yang, Guliang
    Zhong, Haiyan
    Xia, Xinxin
    Qi, Zhiwen
    Wang, Chengzhang
    Li, Shiming
    FOOD SCIENCE AND HUMAN WELLNESS, 2022, 11 (02) : 199 - 207
  • [35] Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin-Proteasome system
    Xie, Hanshu
    Zhang, Chao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 267
  • [36] Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
    Zou, Zhi-feng
    Yang, Lei
    Nie, Hui-jun
    Gao, Jing
    Lei, Shu-min
    Lai, Yi
    Zhang, Fan
    Wagner, Ernst
    Yu, Hai-jun
    Chen, Xiao-hua
    Xu, Zhi-ai
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (08) : 1740 - 1751
  • [37] E3scan™ ligand binding assay platform for targeted protein degradation and PROTAC discovery
    Katsenelson, Ksenya Cohen
    Gonzalez, Luis
    Pallares, Gabriel
    King, Alastair J.
    Treiber, Daniel K.
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Potential application of proteolysis targeting chimera(PROTAC) modification technology in natural products for their targeted protein degradation
    Guliang Yang
    Haiyan Zhong
    Xinxin Xia
    Zhiwen Qi
    Chengzhang Wang
    Shiming Li
    FoodScienceandHumanWellness, 2022, 11 (02) : 199 - 207
  • [39] New Approaches Towards Targeted Protein Degradation
    Yang, J.
    Ting, A.
    Bertozzi, C.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 868 - 868
  • [40] Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
    Burslem, George M.
    Schultz, Anna Reister
    Bondeson, Daniel P.
    Eide, Christopher A.
    Stevens, Samantha L. Savage
    Druker, Brian J.
    Crews, Craig M.
    CANCER RESEARCH, 2019, 79 (18) : 4744 - 4753
12345